Literature DB >> 8543067

Constitutive activity of the M1-M4 subtypes of muscarinic receptors in transfected CHO cells and of muscarinic receptors in the heart cells revealed by negative antagonists.

J Jakubík1, L Bacáková, E E el-Fakahany, S Tucek.   

Abstract

We investigated whether muscarinic receptors of the M1-M4 receptor subtypes are constitutively active. We have found that the synthesis of cyclic AMP was enhanced by the muscarinic antagonists atropine and N-methylscopolamine (NMS) in Chinese hamster ovary (CHO) cells stably transfected with human m2 and m4 muscarinic receptor genes and in rat cardiomyocytes expressing the M2 receptor subtype, and that the production of inositol phosphates was inhibited by atropine and NMS in CHO cells stably transfected with human m1 and m3 and with rat m1 muscarinic receptor genes. The muscarinic antagonists quinuclidinyl benzilate and AF-DX 116 had no effect in some cases and acted like atropine and NMS in others. We conclude that the M1-M4 subtypes of muscarinic receptors are constitutively active in the CHO cell lines expressing them and in cardiomyocytes and that atropine and NMS act as negative antagonists on these receptor subtypes by stabilizing them in the inactive conformation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8543067     DOI: 10.1016/0014-5793(95)01360-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

Review 1.  Inverse agonism at G protein-coupled receptors: (patho)physiological relevance and implications for drug discovery.

Authors:  R A de Ligt; A P Kourounakis; A P IJzerman
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

Review 2.  Genetic variations in human G protein-coupled receptors: implications for drug therapy.

Authors:  W Sadee; E Hoeg; J Lucas; D Wang
Journal:  AAPS PharmSci       Date:  2001

3.  G-protein coupling of mu-opioid receptors (OP3): elevated basal signalling activity.

Authors:  N T Burford; D Wang; W Sadée
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

4.  Cyclic AMP-dependent inotropic effects are differentially regulated by muscarinic G(i)-dependent constitutive inhibition of adenylyl cyclase in failing rat ventricle.

Authors:  R I Hussain; F Afzal; H K Mørk; J M Aronsen; I Sjaastad; J-B Osnes; T Skomedal; F O Levy; K A Krobert
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

5.  A G protein gamma subunit peptide stabilizes a novel muscarinic receptor state.

Authors:  I Azpiazu; N Gautam
Journal:  Biochem Biophys Res Commun       Date:  2006-01-30       Impact factor: 3.575

6.  Activation of muscarinic acetylcholine receptors via their allosteric binding sites.

Authors:  J Jakubík; L Bacáková; V Lisá; E E el-Fakahany; S Tucek
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

7.  Coupling of g proteins to reconstituted monomers and tetramers of the M2 muscarinic receptor.

Authors:  Dar'ya S Redka; Takefumi Morizumi; Gwendolynne Elmslie; Pranavan Paranthaman; Rabindra V Shivnaraine; John Ellis; Oliver P Ernst; James W Wells
Journal:  J Biol Chem       Date:  2014-07-14       Impact factor: 5.157

8.  Inverse agonist activity of pirenzepine at M2 muscarinic acetylcholine receptors.

Authors:  L Daeffler; F Schmidlin; J P Gies; Y Landry
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

9.  Negative cooperativity in binding of muscarinic receptor agonists and GDP as a measure of agonist efficacy.

Authors:  J Jakubík; H Janíčková; E E El-Fakahany; V Doležal
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

10.  Divergence of allosteric effects of rapacuronium on binding and function of muscarinic receptors.

Authors:  Jan Jakubík; Alena Randáková; Esam E El-Fakahany; Vladimír Dolezal
Journal:  BMC Pharmacol       Date:  2009-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.